IL2 and neoplasm: Fibronectin is expressed in the extracellular matrix of vascular endothelial in most solid tumors and malignant blood diseases, so the infusion of L19-IL-2 improves the cytokine index within tumor tissue and increases the median survival in mouse models of sleeve cell lymphoma (44).